Osteoporosis, bone & mineral

Cystinosis-Associated Metabolic Bone Disease Across Ages and Chronic Kidney Disease (CKD) Stages 1 to 5D/T

J Clin Endocrinol MetabPublished Cross-sectional study

An erratum to this article was published (J Clin Endocrinol Metab, 21 Jan 2025 ↗)

Authors' conclusion

Bone health in cystinosis deteriorates with age, which is associated with increased osteoclast activity despite counter-regulation of osteoblasts via OPG/RANKL, which in conjunction with elevated sclerostin levels and persistent rickets/osteomalacia, may promote progressive bone loss.

Study context

Population
Patients with cystinosis (61% children) with CKD stages 1 to 5D/T at hospital clinics61% children
Participants
103 patients
Outcome
Skeletal complications and bone markers
Methodological detailsbinational, multicenter, Ten key bone markers evaluated
  • Binational
  • Multicenter
  • Ten key bone markers evaluated

Main finding

As reported in the abstract

  • Skeletal complications occurred in two-thirds of patients
  • Adults had a 5-fold increased risk of skeletal complications vs children
  • CKD stages 1–3: reduced z-scores for serum phosphate and calcium, suppressed FGF23 and PTH, elevated bone-specific alkaline phosphatase
  • Serum phosphate associated with eGFR, combined phosphate and active vitamin D treatment, and native vitamin D supplementation; serum calcium associated with age and active vitamin D dosage
  • Sclerostin generally elevated in children; associated with age, FGF23, and treatment with active vitamin D and GH
  • Osteoclast marker tartrate-resistant acid phosphatase 5b increased; associated with age and active vitamin D treatment
  • sRANKL/osteoprotegerin (OPG) ratio decreased; associated with phosphate and active vitamin D (calcitriol) levels
  • Changes only partly corrected after transplantation

Observational data: associations, not effects.

Original publication

Cystinosis-Associated Metabolic Bone Disease Across Ages and CKD Stages 1 to 5D/T. J Clin Endocrinol Metab. Published 25 July 2024. doi:10.1210/clinem/dgae502

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.